These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28506471)

  • 1. Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation.
    Riccetti L; De Pascali F; Gilioli L; Santi D; Brigante G; Simoni M; Casarini L
    Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():15-25. PubMed ID: 28506471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus.
    Conforti A; Tüttelmann F; Alviggi C; Behre HM; Fischer R; Hu L; Polyzos NP; Chuderland D; Rama Raju GA; D'Hooghe T; Simoni M; Sunkara SK; Longobardi S
    Front Endocrinol (Lausanne); 2021; 12():797365. PubMed ID: 35178027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
    Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
    Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles.
    Roque M; Bianco B; Christofolini DM; Barchi Cordts E; Vilarino F; Carvalho W; Valle M; Sampaio M; Geber S; Esteves SC; Parente Barbosa C
    Panminerva Med; 2019 Mar; 61(1):76-81. PubMed ID: 29916218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
    Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
    Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.
    Santi D; Casarini L; Alviggi C; Simoni M
    Front Endocrinol (Lausanne); 2017; 8():114. PubMed ID: 28620352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.
    La Marca A; Sighinolfi G; Argento C; Grisendi V; Casarini L; Volpe A; Simoni M
    Fertil Steril; 2013 Mar; 99(4):970-8.e1. PubMed ID: 23380184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
    Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
    J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.
    Alviggi C; Conforti A; Santi D; Esteves SC; Andersen CY; Humaidan P; Chiodini P; De Placido G; Simoni M
    Hum Reprod Update; 2018 Sep; 24(5):599-614. PubMed ID: 29924306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.
    Leão Rde B; Esteves SC
    Clinics (Sao Paulo); 2014; 69(4):279-93. PubMed ID: 24714837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant gonadotropins.
    Lathi RB; Milki AA
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis.
    Oliveira JB; Mauri AL; Petersen CG; Martins AM; Cornicelli J; Cavanha M; Pontes A; Baruffi RL; Franco JG
    J Assist Reprod Genet; 2007; 24(2-3):67-75. PubMed ID: 17195098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.